Frontotemporal dementia is a currently incurable brain disease causing memory loss, speech disorders, and changes in personality. In 5–12% of cases, a decline in progranulin triggers the disease. The loss of this protein ...
Jun 7, 2024
0
103
When we learn something new, our brain cells (neurons) communicate with each other through electrical and chemical signals. If the same group of neurons communicate together often, the connections between them get stronger. ...
Jun 7, 2024
0
10
In a busy hospital waiting room, a young man's muscles began contracting in a harsh, unyielding spasm as a quick-acting student rushed to his aid.
Jun 6, 2024
0
8
TREX1 is a gene that is supposed to direct the maintenance of the entire body's DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a ...
Jun 4, 2024
0
18
University of Queensland researchers have found targeting amyloid plaque in the brain is not essential for ultrasound to deliver cognitive improvement in neurodegenerative disorders.
Apr 2, 2024
0
68
Patients undergoing chemotherapy often experience cognitive effects such as memory impairment and difficulty concentrating—a condition commonly known as "chemo brain."
Mar 6, 2024
0
30
A new study published in Nature Communications gives insights into the underlying mechanisms of the formation of protein clumps in Alzheimer's disease. The study, led by researchers from Karolinska Institutet, could pave ...
Feb 2, 2024
0
29
A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of ...
Jan 22, 2024
0
43
A mouse study designed to shed light on memory loss in people who experience repeated head impacts, such as athletes, suggests the condition could potentially be reversed. The research in mice finds that amnesia and poor ...
Jan 16, 2024
0
49
A randomized controlled trial in Hong Kong finds that the synbiotic drug SIM01 relieves multiple symptoms of long COVID, or post-acute COVID-19 syndrome (PACS).
Dec 29, 2023
0
140
